Does Maternal Incarceration Impact Infants with Neonatal Abstinence Syndrome?

Drago, Matthew J.; Shabanova, Veronika; Hochreiter, Daniela; Grossman, Matthew; Mercurio, Mark R.

doi:10.1007/s10995-021-03356-4

Cited by 5 publications

(8 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 10 studies, 4 of the more recent articles examined the prevalence of opioid use disorder (OUD) among incarcerated pregnant women as a primary focus. 13,23,25,18 The most robust study of OUD among incarcerated women was conducted by Sufrin et al 25 In this large study of monthly pregnancy data from 22 state and federal prison systems and six of the largest county jails, Sufrin et al 25 found that a quarter of pregnant women entering prison have an OUD (26% of women admitted to state prisons and 14% of women admitted to jails, respectively). In a statewide study of pregnant women entering North Carolina’s prison system, the prevalence of OUD was found to be significantly higher.…”

Section: Resultsmentioning

confidence: 99%

“…Ten of the 33 articles that met inclusion criteria for this review reported data relevant to the prevalence of substance use among incarcerated pregnant and postpartum populations 8,13,18,[23][24][25]27,29,35,41 (see Table 2). However, the degree to which assessing the prevalence of substance use was a central aim of the article varied as did the methodology and breadth of substances assessed.…”

Section: Prevalence Of Substance Use Among Incarcerated Pregnant and ...mentioning

confidence: 99%

“…11,12 Maternal incarceration adds to the complexity of treatment and cost, as it is associated with increases in neonatal intensive care unit (NICU) length of stay for infants born with NAS. 13 As such, correctional facilities must be prepared to face the challenges of meeting the immense health needs of perinatal populations in relation to substance use and addiction. Incarcerated pregnant women who use substances prior to and/or during pregnancy are at an increased risk of poor perinatal outcomes; however, the extent to which carceral settings provide treatment for substance use is not well understood.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

An integrative literature review of substance use treatment service need and provision to pregnant and postpartum populations in carceral settings

Smith

Wilson

Zielinski

2023

Womens Health (Lond Engl)

View full text Add to dashboard Cite

Pregnancy is a critical time to provide access to substance use treatment; this is especially true among incarcerated populations, who are known to be at particularly high risk of poor health outcomes. In this integrated literature review, we (1) report what is known about the prevalence of substance use among incarcerated pregnant and postpartum populations; (2) describe substance use treatment programs and current care practices of pregnant and postpartum populations in carceral settings; and (3) explore recommendations and strategies for increasing access to substance use treatment for incarcerated pregnant and postpartum populations. A comprehensive search of seven electronic databases yielded in the retrieval of 139 articles that were assessed for inclusion. Of the retrieved articles, 33 articles met criteria for inclusion in this review. A review of the literature revealed that the understanding of substance use prevalence among pregnant incarcerated women is limited. We also found that treatment of substance use disorders among pregnant and postpartum populations is not routinely available, enhanced perinatal services are sorely needed, and substance use treatment programs are feasible with the help of community partnerships. More research is required to understand current substance use treatment initiatives and outcomes for pregnant women in prison. In addition, strategies for integrating evidence-based, substance use treatment in carceral settings is also needed. Future directions are discussed.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Prevalence Of Substance Use Among Incarcerated Pregnant and ...mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

An integrative literature review of substance use treatment service need and provision to pregnant and postpartum populations in carceral settings

Smith

Wilson

Zielinski

2023

Womens Health (Lond Engl)

View full text Add to dashboard Cite

show abstract

“…This longer hospital LOS for infants born during incarceration is consistent with a Connecticut study of 28 infants born during incarceration compared with 138 infants born to nonincarcerated birthing parents. 26 That study identified treatment with methadone, dyad separation, and lack of breastfeeding as drivers of this difference.…”

Section: Discussionmentioning

confidence: 99%

Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019

et al. 2023

View full text Add to dashboard Cite

Objective: Although medications for opioid use disorder improve both maternal and neonatal outcomes, little is known about opioid-exposed infants born during episodes of incarceration. The study sought to examine birth outcomes for infants born with opioid exposure during perinatal incarceration. Methods: Participants were identified from clinic rosters in a Southeastern women's prison (2016)(2017)(2018)(2019). Included infants born to pregnant people with opioid use disorder incarcerated in the study facility at the time of delivery. We abstracted hospital length of stay, neonatal opioid withdrawal syndrome (NOWS) severity, and discharge plan from hospital records and report descriptive statistics, analysis of variance F tests, and chi-square tests to compare outcomes by opioid exposure type. Results: There were 125 infants born after exposure to methadone (n = 34), buprenorphine (n = 15), oxycodone (n = 22), or no opioid medication (n = 54) during prenatal incarceration. Most infants exposed to methadone or buprenorphine had difficulty with eating, sleeping, or consoling (97% and 80%), and 59% and 47% were treated with medication for NOWS, respectively. The majority with prenatal opioid exposure required intervention for NOWS symptoms after their birthing parent was discharged to the prison. The average hospital length of stay was different for infants with no opioid, methadone, buprenorphine, and oxycodone exposure during incarceration (4, 15, 12, and 9 days, respectively, P < 0.001). Conclusions: Neonatal hospitalization experiences of infants with perinatal opioid exposures during maternal incarceration mirror those of similarly exposed infants born outside the context of incarceration, except for hospital length of stay. Consideration of avoiding separation of the parent-infant dyad may be needed to improve outcomes for these infants.

show abstract